Media
Our latest press releases and resources for media
Here you will find a range of resources including our latest and archived press releases, information on our social media channels, and our photo and video library.
Key information
2021 Second quarter results announcement
We will announce our second quarter 2021 results at 12:00 BST, 07:00 EDT on Wednesday 28 July.
Following the announcement there will be a webcast hosted by Emma Walmsley, CEO, and other members of CET at 14:00 BST, 09:00 EDT.
Press releases for media
- Brian McNamara appointed CEO Designate of new independent Consumer Healthcare company
- ViiV Healthcare presents data from second Dovato (dolutegravir/lamivudine) switch study confirming non-inferior efficacy and no virologic failure versus a broad range of regimens of at least 3 drugs
- ViiV Healthcare study shows new long-acting HIV regimen Cabenuva (cabotegravir/rilpivirine) can be successfully implemented in broad range of US healthcare practices, even during COVID-19
- ViiV Healthcare to present new data from diverse portfolio and pipeline of 2-drug and long-acting regimens for HIV treatment and prevention at IAS 2021
GSK Twitter
-
GSK @GSK
During #SarcomaAwarenessMonth and beyond, we’re committed to driving advances in #oncology cell therapy for patients with these rare cancers. Preview our #ScienceOnTheSofa episode with Dr Sandra D’Angelo from @sloan_kettering for more on the potential of new treatment options.
about 56 minutes ago -
GSK @GSK
We’re creating a growth company: new GSK, with new ambitions for patients and shareholders. #Investors and #media, find out more at gsk.com.
about 4 hours ago
New GSK Investor update
Emma Walmsley, CEO, and other members of CET hosted a virtual investor update on Wednesday 23 June.
The update provided a clear view of the strategy for New GSK, its outlook for growth and the opportunities we see for shareholder value creation.
